S-glutathionylation catalyst diamide also decreases ROS release from permeabilized skeletal muscle mitochondria. by Robert M. Gill (4854028)

“…The final concentration of pyruvate, 2-oxoglutarate, succinate, or palmitoyl-carnitine was 50 μM. n = 4, mean±SEM. (B) The decrease in mitochondrial ROS release correlates with an increase in overall protein S-glutathionylation. …”

Gene ontology biological processes overrepresented among genes exhibiting decreased expression in human psoriasis. by William R. Swindell (175427)

“…<p>A total of 3540 transcripts were identified as significantly decreased in psoriatic plaques obtained from human patients relative to normal skin obtained from control subjects (FDR-adjusted P<0.05 and log₂-transformed fold-change less than -0.50). …”

c-Yes knock-down increases apoptosis and decreases growth in soft-agar and in mouse xenografts. by Florence Sancier (229473)

Down-regulation of the RBP2 protein decreased the tube formation by HUVECs induced by conditioned medium. by Lei Qi (173882)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)

PLD1 inhibition decreases the c-Myc-dependent dNTP biosynthetic transcriptional program. by Harry E. Taylor (596259)

Rhodomyrtone dose dependently decreases production of <i>CXCL1</i>, <i>IL-36G</i>, <i>IL-36RN</i>, <i>MMP-13</i>, <i>S100A7</i>, <i>S100A8</i>, and <i>S100A12</i> transcripts by IL... by Julalak Chorachoo (5855852)

Loss of ALS2 results in decreased levels of the lysosome-dependent degradation of LC3 in fibroblasts. by Shinji Hadano (251529)

“…Scale bars = 50 µm.</p>…”

The mutation D2267N within the G3 domain decreases the complement activation capacity. by Camilla Melin Fürst (402462)

siATF2 treatment decreases γ-globin gene expression in K562 cells. by Li Liu (75607)

Telmisartan decreased NO production in LPS-stimulated BV2 and primary neonatal rat glial cells. by Nofar Torika (3169497)

Metformin treatment blunts hepatocyte fat deposition, increases AMPK phosphorylation, and decreases inflammatory responses. by Shih-Lung Woo (153688)

Increased naive and transitional but decreased memory blood B cells in active chronic sarcoidosis patients. by Anne Saussine (310501)

Methylation levels of the <i>Ucp1</i> promoter decreased following genistein (GEN) treatment. by Noriko Sato (201880)

RhoGTPase inhibition using TcdB and C3 transferase decreases transgene expression. by Anandika Dhaliwal (171763)

Loss of fenestrations and decreased VEGF production in <i>Cyp1b1-/-</i> LSEC. by Juliana Falero-Perez (5905103)

“…Clusters of fenestrations were found aligned in the peripheries of <i>Cyp1b1</i>+/+ LSEC with the expected size of 50–200 nm in diameter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0206756#pone.0206756.ref019" target="_blank">19</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0206756#pone.0206756.ref020" target="_blank">20</a>] (left, arrowheads). …”

The gradual loss of the IFN-γ antiviral effect is accompanied by decreased STAT1 phosphorylation in BMMs. by Yong Shen (284972)

K-means clustering was performed to cluster the genes according to their expression kinetics. by Seon-Pil Jin (17364626)

Mice exposed to neonatal hyperoxia have persistent RVH and decreased vessel density at 21d. by Marta Perez (526067)

Untargeted metabolomic analysis of delayed death-parasites indicates isoprenoid defect and decreased haemoglobin turnover. by Kit Kennedy (4915510)